Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 2/2006

01-01-2006

Pre-diagnosis physical activity and mammographic density in breast cancer survivors

Authors: Melinda L. Irwin, Erin J. Aiello, Anne McTiernan, Richard N. Baumgartner, Kathy B. Baumgartner, Leslie Bernstein, Frank D. Gilliland, Rachel Ballard-Barbash

Published in: Breast Cancer Research and Treatment | Issue 2/2006

Login to get access
Metadata
Title
Pre-diagnosis physical activity and mammographic density in breast cancer survivors
Authors
Melinda L. Irwin
Erin J. Aiello
Anne McTiernan
Richard N. Baumgartner
Kathy B. Baumgartner
Leslie Bernstein
Frank D. Gilliland
Rachel Ballard-Barbash
Publication date
01-01-2006
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 2/2006
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-005-9063-1

Other articles of this Issue 2/2006

Breast Cancer Research and Treatment 2/2006 Go to the issue

OriginalPaper

Effects of raloxifene on normal breast tissue from premenopausal women

OriginalPaper

Complications after breast cancer surgery in patients treated with concomitant preoperative chemoradiation: a case–control analysis

OriginalPaper

Different clinical impact of estradiol receptor determination according to the analytical method: a study on 1940 breast cancer patients over a period of 16 consecutive years

OriginalPaper

Microsatellite profile in hormonal receptor genes associated with breast cancer

Report

Antidepressant use and breast cancer risk

Clinical trial

The (mis)classification of chemo-fog – methodological inconsistencies in the investigation of cognitive impairment after chemotherapy
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits